Noticias

Noticias y análisis de Seiden Law sobre litigios complejos, sanciones y aplicación regulatoria, y recuperación transfronteriza.

The Seiden Law Announces U.S. Shareholders Formation Of A Group To Recover Investor Funds Through A Possible Receivership Over China-Based Huifeng Bio-Pharmaceutical Technology, Inc (Ticker_ HFGB)

Huifeng Bio-Pharmaceutical Technology, Inc. (Ticker: HFGB), is a British Virgin Islands corporation involved in the business of manufacturing and marketing pharmaceutical raw materials and ingredients, such as pharmaceuticals…

marzo 21, 2017 1 minuto de lectura
Noticias de la Firma febrero 8, 2017

The Seiden Law Announces The Addition Of Richard M. Frankel

Richard M. Frankel has joined “The Seiden Law”, a global law firm focusing on judgment enforcement in the United States and globally, general business and financial litigation, court-appointed…